ALBANY, N.Y., Dec. 15, 2023 (GLOBE NEWSWIRE) — A Curia, uma organizao lder em contratos de pesquisa, desenvolvimento e fabricao, anunciou hoje a nomeao de Gerald Auer como Diretor Financeiro. Ele se juntar organizao em 1 de janeiro [...] Read more »
Curia ernennt Gerald Auer zum Chief Financial Officer
ALBANY, New York, Dec. 16, 2023 (GLOBE NEWSWIRE) — Curia, ein fhrendes Auftragsforschungs–, Entwicklungs– und Produktionsunternehmen, gab heute die Ernennung von Gerald Auer zum Chief Financial Officer bekannt. Er wird [...] Read more »
Curia Appoints Gerald Auer as Chief Financial Officer
ALBANY, N.Y., Dec. 15, 2023 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced that Gerald Auer has been appointed as chief financial officer. He will join [...] Read more »
Un nouveau comité consultatif de centre pour Fortrea
DURHAM, État de Caroline du Nord, 14 déc. 2023 (GLOBE NEWSWIRE) — Read more »
Fortrea beruft neuen Prüfzentrumsbeirat ein
DURHAM, North Carolina, Dec. 14, 2023 (GLOBE NEWSWIRE) — Read more »
Fortrea Convoca Novo Conselho Consultivo de Locais
DURHAM, N.C., Dec. 14, 2023 (GLOBE NEWSWIRE) — A Read more »
Fortrea Convenes New Site Advisory Board
DURHAM, N.C., Dec. 13, 2023 (GLOBE NEWSWIRE) — Read more »
Curia rejoint le palmarès 2023 des 10 meilleures entreprises de sous-traitance pharmaceutique en Inde établi par India Pharma Outlook
ALBANY, État de New York, 05 déc. 2023 (GLOBE NEWSWIRE) — Curia, un organisme de premier plan spcialis dans la recherche, le dveloppement et la fabrication sous contrat dans le secteur pharmaceutique, annonce ce jour [...] Read more »
Curia Entra para a Lista das 10 Melhores Empresas CDMO de 2023 da India Pharma Outlook
ALBANY, N.Y., Dec. 05, 2023 (GLOBE NEWSWIRE) — A Curia, uma organizao lder em contratos de pesquisa, desenvolvimento e fabricao, anunciou hoje que entrou para a para a lista das 10 Melhores Empresas CDMO de 2023 da India Pharma [...] Read more »
Curia von India Pharma Outlook auf der Liste der 10 besten CDMO-Unternehmen in Indien für 2023 aufgeführt
ALBANY, New York, Dec. 05, 2023 (GLOBE NEWSWIRE) — Curia, ein fhrendes Auftragsforschungs–, Entwicklungs– und Produktionsunternehmen, hat heute bekanntgegeben, dass es von India Pharma Outlook als [...] Read more »
Global Typhoid Challenges in Focus at International Conference in Rwanda
KIGALI, Rwanda, Dec. 05, 2023 (GLOBE NEWSWIRE) — The 13th International Conference on Typhoid & Other Invasive Salmonelloses gets under way today in Kigali, Rwanda, with nearly 350 researchers, healthcare [...] Read more »
Curia Recognized on India Pharma Outlook’s 2023 List of Top 10 CDMO Companies in India
ALBANY, N.Y., Dec. 05, 2023 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced it has been recognized as one of the top 10 CDMOs in India by India Pharma [...] Read more »
Zenas BioPharma Fortalece a Liderança Executiva com a Nomeação de Jennifer Fox como Diretora de Negócios e Financeira, e de Tanya Fischer, MD, Ph.D. como Dirigente de P&D e Médica
WALTHAM, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) — A Zenas BioPharma, uma empresa biofarmacutica global comprometida em se tornar lder no desenvolvimento e comercializao de terapias voltadas para inflamaes e imunologia (I&I), [...] Read more »
Zenas BioPharma stärkt seine Führungsspitze mit der Ernennung von Jennifer Fox als Chief Business Officer und Chief Financial Officer sowie von Tanya Fischer, M.D., PhD. als Leiterin von Forschung und Entwicklung und als Chief Medical Officer
WALTHAM, Massachusetts, Dec. 04, 2023 (GLOBE NEWSWIRE) — Zenas BioPharma, ein weltweit ttiges Biopharmazieunternehmen, das sich der Aufgabe verschrieben hat, eine fhrende Position in der Entwicklung und Vermarktung von [...] Read more »
Zenas BioPharma renforce sa direction avec la nomination de Jennifer Fox en tant que Chief Business Officer et Chief Financial Officer et de Tanya Fischer, M.D., PhD., en tant que Head of R&D et Chief Medical Officer
WALTHAM, Massachusetts, 04 déc. 2023 (GLOBE NEWSWIRE) — Zenas BioPharma, un laboratoire biopharmaceutique d'envergure mondiale dtermin devenir un leader dans le dveloppement et la commercialisation de traitements dans les [...] Read more »